No place like home? Outpatient management of patients with febrile neutropenia and low risk.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.The Cochrane database of systematic reviews · 2013
   Pooled it
2. Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia.PloS one · 2012
   Pooled it
3. Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
   Article
4. The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2017
   Article
5. Responding to Acute Care Needs of Patients With Cancer: Recent Trends Across Continents.The oncologist · 2016
   Review
6. Clinical and economic burden of emergency department presentations for neutropenia following outpatient chemotherapy for cancer in Victoria, Australia.The oncologist · 2012
   Article

Corrections and comments

• Comment on
  Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial.2011
• Comment on
  Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial.2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as